US$ 24.45
glp-1 companies list The Peptide Paradox: Why Miracle Drugs Might Be Making Us Weaker The Next Big Weight Loss
Description
De Pablo-Fernandez E, Goldacre R, Pakpoor J, Noyce AJ, Warner TT

Design of a long acting peptide functioning as both a glucagon-like peptide-1 receptor agonist and a glucagon receptor antagonist
PAK: Pakistan

February 26, 2024
